Breakthrough in Intensive Care Diagnostics In a significant advancement for critical care medicine, researchers have demonstrated how nanopore long-read genome…
The New Era of Personalized Preventive Care In today’s digitally-driven world, personalized experiences have become the expectation rather than the…
OpenEvidence’s Meteoric Valuation Jump In a stunning demonstration of investor confidence in healthcare artificial intelligence, OpenEvidence has secured $200 million…
The Elusive Nature of HIV For decades, HIV has remained one of medicine’s most formidable adversaries, not because we lack…
Researchers have reportedly achieved a significant breakthrough in treating severe macular degeneration using a wireless retinal implant. According to recent findings, the technology has enabled previously blind patients to regain enough vision to read, marking a potential turning point in vision restoration technology.
Researchers have reportedly restored partial vision to patients suffering from advanced macular degeneration using an innovative retinal implant technology, according to a study published in The New England Journal of Medicine. Sources indicate that the prosthetic device could potentially help approximately one million people in the United States alone who struggle with geographic atrophy, the most severe form of age-related macular degeneration.
Researchers have generated a comprehensive long-read RNA sequencing dataset from ten human pancreatic cancer cell lines. The data provides unprecedented insights into transcriptomic variations driving pancreatic cancer progression. This resource enables detailed analysis of alternative splicing and protein isoforms relevant to tumor biology.
Scientists have generated a comprehensive RNA sequencing dataset using advanced long-read technology to profile ten human pancreatic cancer cell lines, according to reports published in Scientific Data. The research team employed nanopore long-read RNA sequencing, which reportedly enables detection of splicing events, alternative polyadenylation, and open reading frames that are often missed by conventional short-read methods. Sources indicate this approach offers crucial insights into transcriptome-wide changes with implications for drug resistance, tumor progression, and metastasis.
Medical Miracle: From Darkness to Reading Again In what medical professionals are calling a revolutionary advancement in vision restoration technology,…
Activist investor Jana Partners has built a position in Cooper Companies and is advocating for strategic changes, sources indicate. The investor reportedly sees potential in combining Cooper’s contact-lens business with rival Bausch + Lomb, whose CEO has expressed interest in such a deal.
Activist investment firm Jana Partners has reportedly acquired a significant stake in Cooper Companies, the medical device manufacturer known for its CooperVision contact lens division, according to people familiar with the matter. Sources indicate the firm plans to push for strategic alternatives that could include a potential combination of Cooper’s vision-care unit with rival Bausch + Lomb.
The Growing Concern of Age-Related Sperm Mutations Groundbreaking research has revealed a concerning biological phenomenon: as men age, their sperm…
The Strategic Fit Behind Samsung’s Digital Health Acquisition When Samsung announced its acquisition of digital health platform Xealth for approximately…
